Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AAAS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | AADACL2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | AAED1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | AARS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ABC13-47656900H15.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | ABCD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | ABHD17C | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ABHD2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | ABI3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |